Navigation Links
INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
Date:3/18/2009

dose we've explored in the clinic to date and the dose of R7128 is only one-half the dose currently being studied in the clinic, we look forward to presenting the results of subsequent higher dose cohorts of INFORM-1."

INFORM-1 Study Design

The following information regarding the INFORM-1 study is available on www.clinicaltrials.gov:

  • Patients in Cohort A are dosed in two groups, Group A and Group B. Patients in Group A receive 500mg BID of R7128 as monotherapy for three days followed by four days of combination therapy comprised of the same dose of R7128 plus 100mg q8h of ITMN-191. Patients in Group B receive 100mg q8h of ITMN-191 as monotherapy for three days followed by four days of combination therapy comprised of the same dose of ITMN-191 plus 500mg BID of R7128.
  • Patients in Cohort B receive the same doses of R7128 and ITMN-191 as patients in both groups of Cohort A, but for a full 14 days in combination. Cohort B is referred to as Group C in the EASL abstract.
  • Patients in Cohort C are dosed in two groups, Group D and Group E. Patients in Group D receive 1000 mg BID of R7128 and 100mg q8h of ITMN-191 for 14 days. Patients in Group E receive 500 mg BID of R7128 and 200 mg q8h of ITMN-191 for 14 days.
  • Patients in Cohort D are dosed in one Group (Group F) and receive 1000 mg BID of R7128 and 200 mg of ITMN-191 q8h for 14 days.

About EASL

The European Association for the Study of the Liver (EASL) is the leading European association in the field of liver research. EASL brings together clinicians and scientists interested in the liver, providing an outlet for networking and learning. The EASL Annual Meeting attracts more than 7,000 participants annually.

About InterMune

Inte
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
2. Arpida Interim Results for six Months to 30 June 2007
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
5. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
6. IsoTis Reports Interim Results of Vote for Integra Merger
7. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
8. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
9. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
10. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
11. VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® ... bearings are uniquely suited to prevent loss of lubrication ... the high temperatures . , Recently, a manufacturer ... engineers at Graphite Metallizing to overcome problems with movement ... operation, pans containing blocks of powder mixture are loaded ...
(Date:7/31/2014)... July 31, 2014 According to ... "Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, ... - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - ... 2013 - 2019," the global electrodes market for medical ... and is estimated to reach a market worth USD ...
(Date:7/31/2014)... California (PRWEB) July 31, 2014 CollabRx, ... that inform therapeutic decision-making in oncology, today announced that ... 14, 2014 to discuss the Company's financial results for ... an update about the business in the current fiscal ... call beginning on Thursday, August 14, 2014, at 5 ...
(Date:7/31/2014)...  Smith & Nephew (LSE:SN, NYSE: ... announced its entry into the forefoot market with ... System. Comprised of three separate repair options, the ... repair and reconstruction, a metatarsal osteotomy guide, and ... fusion, also known as hammer toe correction. ...
Breaking Biology Technology:Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 2Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 4Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 5Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 6CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4
... Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial ... Total revenue increased to $49.8 million in the first ... of 2010.  Product revenue was $49.5 million in the first quarter ... in the first quarter of 2010. Net loss ...
... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX ... biotechnology company focused on researching, developing, manufacturing and ... release its first quarter 2011 unaudited financial results ... May 11, 2011 at 8:00pm (US Eastern ). ...
... May 3, 2011 Novavax, Inc. (Nasdaq: NVAX ... 2011 on Monday, May 9, 2011, before the U.S. financial ... and conference call hosted by Stanley C. Erck, President and ... 10:00 a.m. Eastern time. The webcast and ...
Cached Biology Technology:Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 2Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 3Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 4Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 5Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 6Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 7Genomic Health Announces First Quarter 2011 Financial Results and Business Progress 83SBio Inc. Schedules Unaudited First Quarter 2011 Results 2
(Date:7/31/2014)... biomass burning burning forests to create agricultural ... agriculture and wildfires figures into both climate ... release of a new study by Stanford University ... the degree of that contribution had never been ... paper published July 30 in the Journal ...
(Date:7/31/2014)... Kansas State University researchers have completed a 20-year ... Flint Hills prairie at different times of the ... current late spring time frame has no measurable ... may have multiple benefits. , The study was ... Konza Prairie Biological Station fire chief, and Joseph ...
(Date:7/31/2014)... people make a rational choice to be liberal or ... it a matter of genetics?, Two political scientists from ... University say that neither conscious decision-making nor parental upbringing ... lean right. , A growing body of evidence shows ... core of political differences, the researchers say in the ...
Breaking Biology News(10 mins):Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3Scientists find growing consensus: Political attitudes derive from body and mind 2
... more uses for local farm products were the focus of ... on selected Ontario farms. This province-wide initiative is the only ... farms to evaluate the effectiveness of using biodiesel in agriculture. ... adoption of biodiesel use on Ontario farms through a series ...
... medicine technique and molecular imaging to "see" programmed cell ... or abnormal cells—may help in early identification of those ... say researchers in the April Journal of Nuclear Medicine. ... noninvasively identify cell loss—or apoptosis—in heart failure patients using ...
... they can display a comparable pattern of neural activity ... Max Planck Institute for Dynamics and Self-Organization in Göttingen ... from neural cells which exhibit a predefined pattern dynamics. ... in getting closer to understanding which of the possible ...
Cached Biology News:Biodiesel study targets cleaner air, cleaner engines 2Heart failure: Intervention possibilities from imaging programmed cell loss 22 brains -- 1 thought 22 brains -- 1 thought 3